Shopping Cart
- Remove All
Your shopping cart is currently empty
Elisidepsin (PM02734), a cyclic depsipeptide, exhibits antineoplastic activity by inhibiting cancer cell proliferation and is under research for the treatment of various cancers, including non-small cell lung cancer (NSCLC) [1] [2] [3] [4].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks |
| Description | Elisidepsin (PM02734), a cyclic depsipeptide, exhibits antineoplastic activity by inhibiting cancer cell proliferation and is under research for the treatment of various cancers, including non-small cell lung cancer (NSCLC) [1] [2] [3] [4]. |
| In vitro | Elisidepsin, administered over 72 hours, suppresses the proliferation of diverse cancer cell types, demonstrating half-maximal inhibitory concentration (IC50) values starting from 0. |
| In vivo | Elisidepsin administered intravenously at a dose of 100 µg/kg demonstrates efficacy in inhibiting lung cancer xenografts [3]. |
| Synonyms | PM02734 |
| Molecular Weight | 1477.87 |
| Formula | C75H124N14O16 |
| Cas No. | 681272-30-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.